I. Expression across cell types
Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| hepatocyte | 5 studies | 62% ± 15% | |
| endothelial cell | 3 studies | 18% ± 2% | |
| mesothelial cell | 3 studies | 32% ± 11% |
Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| hepatocyte | 5 studies | 62% ± 15% | |
| endothelial cell | 3 studies | 18% ± 2% | |
| mesothelial cell | 3 studies | 32% ± 11% |
Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| liver | 4 studies | 29% ± 10% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| liver | 100% | 42927.42 | 226 / 226 | 99% | 82.67 | 401 / 406 |
| thymus | 100% | 4180.59 | 653 / 653 | 95% | 9.46 | 574 / 605 |
| kidney | 100% | 6391.40 | 89 / 89 | 90% | 12.97 | 808 / 901 |
| ovary | 98% | 1355.99 | 176 / 180 | 88% | 6.88 | 377 / 430 |
| brain | 90% | 679.27 | 2372 / 2642 | 93% | 10.74 | 656 / 705 |
| pancreas | 99% | 999.10 | 326 / 328 | 76% | 3.30 | 135 / 178 |
| prostate | 98% | 1544.27 | 240 / 245 | 75% | 3.78 | 378 / 502 |
| uterus | 98% | 956.14 | 166 / 170 | 69% | 3.83 | 316 / 459 |
| skin | 97% | 1345.90 | 1754 / 1809 | 67% | 3.69 | 317 / 472 |
| bladder | 90% | 722.62 | 19 / 21 | 68% | 3.98 | 345 / 504 |
| adrenal gland | 100% | 2820.65 | 258 / 258 | 57% | 3.59 | 130 / 230 |
| intestine | 95% | 887.31 | 922 / 966 | 58% | 2.95 | 305 / 527 |
| breast | 99% | 1140.53 | 454 / 459 | 54% | 2.89 | 606 / 1118 |
| stomach | 95% | 742.84 | 340 / 359 | 54% | 2.77 | 154 / 286 |
| lung | 95% | 786.09 | 551 / 578 | 52% | 2.48 | 604 / 1155 |
| esophagus | 89% | 583.97 | 1290 / 1445 | 28% | 1.22 | 52 / 183 |
| spleen | 100% | 1597.46 | 241 / 241 | 0% | 0 | 0 / 0 |
| ureter | 0% | 0 | 0 / 0 | 100% | 12.03 | 1 / 1 |
| adipose | 97% | 1708.94 | 1163 / 1204 | 0% | 0 | 0 / 0 |
| blood vessel | 77% | 423.76 | 1023 / 1335 | 0% | 0 | 0 / 0 |
| lymph node | 0% | 0 | 0 / 0 | 59% | 1.92 | 17 / 29 |
| peripheral blood | 48% | 356.48 | 446 / 929 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 45% | 1.91 | 36 / 80 |
| heart | 39% | 205.21 | 340 / 861 | 0% | 0 | 0 / 0 |
| muscle | 27% | 128.49 | 214 / 803 | 0% | 0 | 0 / 0 |
| tonsil | 0% | 0 | 0 / 0 | 24% | 0.87 | 11 / 45 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| GO_2000479 | Biological process | regulation of cAMP-dependent protein kinase activity |
| GO_0006508 | Biological process | proteolysis |
| GO_0046425 | Biological process | regulation of receptor signaling pathway via JAK-STAT |
| GO_0045721 | Biological process | negative regulation of gluconeogenesis |
| GO_0005615 | Cellular component | extracellular space |
| GO_0005576 | Cellular component | extracellular region |
| GO_0062023 | Cellular component | collagen-containing extracellular matrix |
| GO_0004175 | Molecular function | endopeptidase activity |
| GO_0005515 | Molecular function | protein binding |
| GO_0030971 | Molecular function | receptor tyrosine kinase binding |
| Gene name | MST1 |
| Protein name | Hepatocyte growth factor-like protein (Macrophage stimulatory protein) (Macrophage-stimulating protein) (MSP) [Cleaved into: Hepatocyte growth factor-like protein alpha chain; Hepatocyte growth factor-like protein beta chain] Macrophage stimulating 1 MST1 protein |
| Synonyms | DNF15S2 D3F15S2 HGFL hCG_2001992 |
| Description | |
| Accessions | G3XAK1 ENST00000448220.5 ENST00000449682.3 H7C0F8 Q49A61 P26927 |
